Do higher levels of oxidizable lipids in lipoproteins together with Lp-PLA2 activity promote endothelial dysfunction?

The synthesis of biochemical and clinical evidence supports the claim that the composition of lipids within lipoproteins directly influences the formation of oxidized LDL (oxLDL) and that the subsequent enzymatic action of Lp-PLA2 drives endothelial dysfunction.

Lipid substrate and LDL oxidation

The availability of oxidizable lipids, particularly omega-6 polyunsaturated fatty acids (PUFAs) like linoleic acid (LA), is a critical determinant of LDL’s susceptibility to oxidation.

• Substrate availability: Linoleic acid is the most abundant PUFA in LDL, typically representing 50-60% of its fatty acid content. Research shows a strong correlation (r=0.89) between the percentage of LA in LDL and the formation of conjugated dienes, a primary marker of lipid oxidation.
• Enzymatic targeting: Enzymes such as 15-lipoxygenase (15-LOX) preferentially target cholesteryl esters containing linoleic acid, accelerating the transition from native LDL to its pro-inflammatory oxidized form.

Lp-PLA2 and inflammatory mediators

Lp-PLA2 (lipoprotein-associated phospholipase A2) serves as a key link between lipid oxidation and vascular inflammation through its highly specific enzymatic activity.

• Selectivity for oxidized lipids: Lp-PLA2 does not act on native phospholipids but specifically recognizes and hydrolyzes oxidized phospholipids (OxPLs) at the sn-2 position of the glycerol backbone.
• Generation of bioactive products: The hydrolysis of OxPLs by Lp-PLA2 generates two potent inflammatory mediators: lysophosphatidylcholine (lyso-PC) and oxidized non-esterified fatty acids (oxNEFAs).

Mechanisms of endothelial dysfunction

The mediators produced by Lp-PLA2 activity directly impair endothelial health through several well-characterized pathways:

• Adhesion and recruitment: Lyso-PC upregulates critical adhesion molecules, including VCAM-1, ICAM-1, and E-selectin, via TLR4/NF-κB signaling. This process facilitates the recruitment of macrophages to the vascular wall, a hallmark of early atherosclerosis.
• Impaired nitric oxide bioavailability: These mediators reduce the expression and function of endothelial nitric oxide synthase (eNOS) while increasing reactive oxygen species (ROS). Furthermore, lyso-PC elevates levels of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of eNOS, which significantly attenuates endothelium-dependent vasorelaxation.

Bottom line

Higher concentrations of oxidizable omega-6 lipids increase the formation of oxidized LDL. Lp-PLA2 then acts on these oxidized particles to release lyso-PC and oxidized fatty acids, which promote vascular inflammation and impair endothelial function by reducing nitric oxide production and increasing oxidative stress.